News from emmaus life sciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 24, 2014, 16:53 ET

Emmaus Life Sciences presentará ensayos clínicos de anemia drepanocítica de fase 3 en la 56a. Reunión Anual de la Sociedad Estadounidense de Hematología

Emmaus Life Sciences, Inc. (la "Compañía" o "Emmaus"), anunció hoy que el Dr. Yutaka Niihara, M.D., M.P.H., fundador y CEO de...

Nov 24, 2014, 08:43 ET

Emmaus Life Sciences To Present Phase 3 Sickle Cell Disease Trial Data At 56th American Society Of Hematology Annual Meeting

 Emmaus Life Sciences, Inc. (the "Company," or "Emmaus"), today announced that Dr. Yutaka Niihara, M.D., M.P.H., founder and CEO of Emmaus,...

May 22, 2014, 08:00 ET

Emmaus Life Sciences Appoints New Members To Board Of Directors

Emmaus Life Sciences, Inc., a biopharmaceutical company dedicated primarily to the discovery, development and commercialization of innovative...

Mar 20, 2014, 08:00 ET

Emmaus Life Sciences anuncia resultados principales positivos de su ensayo clínico de Fase 3 para la enfermedad de células falciformes

 Emmaus Life Sciences, Inc. (la "Compañía", o "Emmaus"), una compañía biofarmacéutica dedicada principalmente al...

Mar 20, 2014, 07:00 ET

Emmaus Life Sciences anuncia resultados de primeira linha positivos do seu ensaio clínico de fase 3 sobre anemia falciforme

 Emmaus Life Sciences, Inc. (a "empresa", ou "Emmaus"), uma empresa biofarmacêutica dedicada principalmente à descoberta,...

Mar 20, 2014, 03:00 ET

Emmaus Life Sciences meldet positive Topline-Ergebnisse seiner klinischen Phase-3-Studie über die Sichelzellenkrankheit

 Emmaus Life Sciences, Inc. (das „Unternehmen" oder „Emmaus"), ein in erster Linie auf die Entdeckung, Entwicklung und...

Mar 20, 2014, 03:00 ET

Emmaus Life Sciences anuncia unos resultados positivos de su ensayo clínico de fase 3 para la anemia falciforme

 Emmaus Life Sciences, Inc. (la "Compañía" o "Emmaus"), una compañía biofarmacéutica dedicada principalmente al...

Mar 20, 2014, 03:00 ET
Mar 19, 2014, 08:00 ET

Emmaus Life Sciences Announces Positive Top-Line Results Of Its Phase 3 Clinical Trial For Sickle Cell Disease

 Emmaus Life Sciences, Inc. (the "Company," or "Emmaus"), a biopharmaceutical company dedicated primarily to the discovery, development and...

Sep 16, 2013, 08:00 ET

Emmaus Life Sciences Announces Closing Of $7.5 Million Private Placement

Emmaus Life Sciences, Inc. (the "Company," or "Emmaus"), a biotherapeutics company dedicated primarily to the discovery, development and...

Jul 01, 2013, 08:00 ET

Emmaus Life Sciences Cancels Stock Held By AFH Holding & Advisory And Amir Heshmatpour

 Emmaus Life Sciences, Inc., a company dedicated to the discovery, development and commercialization of innovative and cost effective treatment...

May 16, 2013, 08:00 ET

Emmaus Life Sciences Wins Sweeping Summary Judgment Victory In Suit Against AFH Holding & Advisory and Amir Heshmatpour

 Emmaus Life Sciences, Inc., a company dedicated to the discovery, development and commercialization of innovative and cost effective...

Jan 25, 2013, 15:40 ET

Emmaus Life Sciences Issues Statement in Response to Announcement by AFH Holding & Advisory

Emmaus Life Sciences, Inc., a company dedicated to the discovery, development and commercialization of innovative and cost effective treatments and...

Oct 10, 2012, 11:00 ET

Emmaus Life Sciences Issues Statement In Response to Announcement by AFH Holding & Advisory

Emmaus Life Sciences, Inc., a specialty pharmaceutical and regenerative medicine company, today issued the following statement in response to an...